Gut microbiome as a biomarker of cardiometabolic disorders

Introduction and objective Cardiovascular diseases are the leading cause of death in Europe and worldwide. One of the most important risk factors for atherosclerosis are lipid metabolism disorders, in particular hipercholesterolaemia. The aim of the study was to determine the correlation between gut...

Full description

Bibliographic Details
Main Authors: Anna Gózd-Barszczewska, Maria Kozioł-Montewka, Piotr Barszczewski, Agata Młodzińska, Kinga Humińska
Format: Article
Language:English
Published: Institute of Rural Health 2017-09-01
Series:Annals of Agricultural and Environmental Medicine
Subjects:
Online Access:http://www.journalssystem.com/aaem/The-Gut-Microbiome-as-a-biomarker-of-cardiometabolic-disorders,75456,0,2.html
id doaj-f7b698a1e1d24198a763d156d3c2b0c9
record_format Article
spelling doaj-f7b698a1e1d24198a763d156d3c2b0c92020-11-25T02:29:37ZengInstitute of Rural HealthAnnals of Agricultural and Environmental Medicine1232-19661898-22632017-09-0124341642210.26444/aaem/7545675456Gut microbiome as a biomarker of cardiometabolic disordersAnna Gózd-Barszczewska0Maria Kozioł-Montewka1Piotr Barszczewski2Agata Młodzińska3Kinga Humińska4Division of Cardiology with Cardiac Intensive Care Unit, Cardinal Stefan Wyszyński Hospital, Lublin, PolandPope John Paul II State School of Higher Education, Biała Podlaska, PolandChair and Department of Medical Microbiology, Medical University, Lublin, Poland; Division of Gastroenterology, Cardinal Stefan Wyszyński Hospital, Lublin, PolandGenomic Laboratory, DNA Research Centre, Poznań, PolandGenomic Laboratory, DNA Research Centre, Poznań, Poland; Laboratory of High Throughput Technologies, Institute of Molecular Biology and Biotechnology, Faculty of Biology, Adam Mickiewicz University, Poznan, PolandIntroduction and objective Cardiovascular diseases are the leading cause of death in Europe and worldwide. One of the most important risk factors for atherosclerosis are lipid metabolism disorders, in particular hipercholesterolaemia. The aim of the study was to determine the correlation between gut microbiota composition and atherosclerosis risk factors, so in order that it might be used as a biomarker for coronary artery disease diagnosis. Material and methods The study involved middle-aged men in eastern Poland with central obesity (n=20), subjects with atherosclerosis (n=15) and those with no cardiovascular diseases (n=5). The gut microbiota composition was determined using tag-encoded 16S rRNA gene using Illuminal MiSeq. Data were analyzed with the use of t-test. Results Firmicutes (49.26%) and Bacteroidetes (44.46%) were the dominant Phyla in the middle-aged men in eastern Poland. Subjects with improper levels of total cholesterol were enriched in Prevotella (p=0.03) and decreased level of Clostridium (p=0.02). They also showed a falling tendency in Faecalibacterium (p=0.07). An upward trend was observed in Prevotella (p=0.07) in subjects with improper LDL-C values. Conclusions The study showed that intestinal microbiome is likely to play a role in the pathogenesis of atherosclerosis through its role in lipid metabolism. Bacterial genera of particular importance were Prevotella, Bacteroides, Clostridium, Faecalibacterium. However, further studies involving larger groups of subjects are required to confirm these observations.http://www.journalssystem.com/aaem/The-Gut-Microbiome-as-a-biomarker-of-cardiometabolic-disorders,75456,0,2.htmlgut microbiotaatherosclerosislipid disordersmicrobiomecardiovascular diseases
collection DOAJ
language English
format Article
sources DOAJ
author Anna Gózd-Barszczewska
Maria Kozioł-Montewka
Piotr Barszczewski
Agata Młodzińska
Kinga Humińska
spellingShingle Anna Gózd-Barszczewska
Maria Kozioł-Montewka
Piotr Barszczewski
Agata Młodzińska
Kinga Humińska
Gut microbiome as a biomarker of cardiometabolic disorders
Annals of Agricultural and Environmental Medicine
gut microbiota
atherosclerosis
lipid disorders
microbiome
cardiovascular diseases
author_facet Anna Gózd-Barszczewska
Maria Kozioł-Montewka
Piotr Barszczewski
Agata Młodzińska
Kinga Humińska
author_sort Anna Gózd-Barszczewska
title Gut microbiome as a biomarker of cardiometabolic disorders
title_short Gut microbiome as a biomarker of cardiometabolic disorders
title_full Gut microbiome as a biomarker of cardiometabolic disorders
title_fullStr Gut microbiome as a biomarker of cardiometabolic disorders
title_full_unstemmed Gut microbiome as a biomarker of cardiometabolic disorders
title_sort gut microbiome as a biomarker of cardiometabolic disorders
publisher Institute of Rural Health
series Annals of Agricultural and Environmental Medicine
issn 1232-1966
1898-2263
publishDate 2017-09-01
description Introduction and objective Cardiovascular diseases are the leading cause of death in Europe and worldwide. One of the most important risk factors for atherosclerosis are lipid metabolism disorders, in particular hipercholesterolaemia. The aim of the study was to determine the correlation between gut microbiota composition and atherosclerosis risk factors, so in order that it might be used as a biomarker for coronary artery disease diagnosis. Material and methods The study involved middle-aged men in eastern Poland with central obesity (n=20), subjects with atherosclerosis (n=15) and those with no cardiovascular diseases (n=5). The gut microbiota composition was determined using tag-encoded 16S rRNA gene using Illuminal MiSeq. Data were analyzed with the use of t-test. Results Firmicutes (49.26%) and Bacteroidetes (44.46%) were the dominant Phyla in the middle-aged men in eastern Poland. Subjects with improper levels of total cholesterol were enriched in Prevotella (p=0.03) and decreased level of Clostridium (p=0.02). They also showed a falling tendency in Faecalibacterium (p=0.07). An upward trend was observed in Prevotella (p=0.07) in subjects with improper LDL-C values. Conclusions The study showed that intestinal microbiome is likely to play a role in the pathogenesis of atherosclerosis through its role in lipid metabolism. Bacterial genera of particular importance were Prevotella, Bacteroides, Clostridium, Faecalibacterium. However, further studies involving larger groups of subjects are required to confirm these observations.
topic gut microbiota
atherosclerosis
lipid disorders
microbiome
cardiovascular diseases
url http://www.journalssystem.com/aaem/The-Gut-Microbiome-as-a-biomarker-of-cardiometabolic-disorders,75456,0,2.html
work_keys_str_mv AT annagozdbarszczewska gutmicrobiomeasabiomarkerofcardiometabolicdisorders
AT mariakoziołmontewka gutmicrobiomeasabiomarkerofcardiometabolicdisorders
AT piotrbarszczewski gutmicrobiomeasabiomarkerofcardiometabolicdisorders
AT agatamłodzinska gutmicrobiomeasabiomarkerofcardiometabolicdisorders
AT kingahuminska gutmicrobiomeasabiomarkerofcardiometabolicdisorders
_version_ 1724831984069378048